Vimarsana
Biggest News Aggregation in the World

Page 29 - Caredx Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Caredx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Caredx Inc Today - Breaking & Trending Today

CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation - Vimarsana News

CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation

CareDx Exclusive Provider of dd-cfDNA Testing Services for Use in Miromatrix Clinical Trials Companies at Forefront of Alternative Organ Supply Research to Address Organ Shortage ... | April 5, 2023

Reginald Seeto Sells 2,818 Shares of CareDx, Inc (NASDAQ:CDNA) Stock - Vimarsana News

Reginald Seeto Sells 2,818 Shares of CareDx, Inc (NASDAQ:CDNA) Stock

CareDx, Inc (NASDAQ:CDNA – Get Rating) insider Reginald Seeto sold 2,818 shares of the stock in a transaction that occurred on Monday, April 3rd. The shares were sold at an average price of $8.95, for a total transaction of $25,221.10. Following the transaction, the insider now owns 537,815 shares in the company, valued at approximately […]

Reginald Seeto Sells 2,818 Shares of CareDx, Inc (NASDAQ:CDNA) Stock - Vimarsana News

Reginald Seeto Sells 2,818 Shares of CareDx, Inc (NASDAQ:CDNA) Stock

CareDx, Inc (NASDAQ:CDNA – Get Rating) insider Reginald Seeto sold 2,818 shares of CareDx stock in a transaction on Monday, April 3rd. The shares were sold at an average price of $8.95, for a total transaction of $25,221.10. Following the completion of the transaction, the insider now owns 537,815 shares in the company, valued at […]

CareDx, Inc (NASDAQ:CDNA) Receives $16.00 Consensus Price Target from Brokerages - Vimarsana News

CareDx, Inc (NASDAQ:CDNA) Receives $16.00 Consensus Price Target from Brokerages

CareDx, Inc (NASDAQ:CDNA – Get Rating) has been given an average recommendation of “Hold” by the six brokerages that are covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month target price among […]

CareDx, Inc (NASDAQ:CDNA) Q4 2022 Earnings Call Transcript - Vimarsana News

CareDx, Inc (NASDAQ:CDNA) Q4 2022 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to the CareDx, Incorporated Fourth Quarter 2022 Earnings Conference Call. Today's conference is being recorded.